HT
HRMY icon

Headlands Technologies’s Harmony Biosciences HRMY Stock Holding History

Headlands Technologies’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-482
Closed -$16.6K – 1312
2024
Q4 		$16.6K Buy
+482
New +$16.6K ﹤0.01% 954
2024
Q3 		– Sell
-2,545
Closed -$76.8K – 1336
2024
Q2 		$76.8K Buy
2,545
+2,396
+1,608% +$72K 0.01% 697
2024
Q1 		$5K Buy
+149
New +$4.78K ﹤0.01% 1103
2023
Q4 		– Sell
-689
Closed -$22.6K – 1089
2023
Q3 		$22.6K Buy
+689
New +$23.9K 0.01% 576

Other funds holding HRMY

VM
Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Headlands Technologies's HRMY Position: Q1 2025 in Review

Headlands Technologies sold out of Harmony Biosciences (HRMY) in Q1 2025, closing a stake of 482 shares — an estimated $16.6K sold.

Headlands Technologies first reported a position in HRMY in Q3 2023 and held it in 4 quarters. The position peaked at $76.8K in Q2 2024. 272 funds tracked by Wall St. Rank hold HRMY as of Q1 2025.

  • Headlands Technologies reported no remaining Harmony Biosciences position as of Q1 2025 after selling out during the quarter.
  • Headlands Technologies sold 482 Harmony Biosciences shares in Q1 2025, an estimated $16.6K.
  • Headlands Technologies first reported a position in Harmony Biosciences in Q3 2023 and held it in 4 quarters.
  • Headlands Technologies's Harmony Biosciences position peaked at $76.8K in Q2 2024.
  • 272 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2025.

Based on Headlands Technologies's 13F filing for Q1 2025, filed 9 May 2025.